EQT has formally entered the Japan market – striking a partnership with Japan Industrial Partners (JIP) to aid its local penetration – as part of a broader plan to increase its Asia private equity exposure.
The Europe-headquartered GP has opened an office in Tokyo and is in the process of building a local team, which will be complemented by existing resources within the global network. The EQT-JIP relationship...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.